Genomictree Inc. (KOSDAQ:228760)
15,720
+500 (3.29%)
Apr 1, 2025, 3:30 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 377.12 billion as of April 1, 2025. Its market cap has decreased by -27.30% in one year.
Market Cap
377.12B
Enterprise Value
283.56B
Revenue
2.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
15,720.00
Market Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 377.12B, an increase of 539.21%. That is a compound annual growth rate of 26.13%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 74.66T |
Celltrion | 38.03T |
ALTEOGEN | 18.79T |
Yuhan | 8,537.79B |
SK Biopharmaceuticals | 7,893.98B |
HLB Co., Ltd. | 7,500.72B |
Sam Chun Dang Pharm. | 3,930.51B |
PharmaResearch | 3,506.51B |